Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)
Status:
Completed
Trial end date:
2016-01-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and activity of the combination of
lenalidomide with intermediate dose dexamethasone and cyclophosphamide in patients with
primary systemic (AL ) amyloidosis.